• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MacroGenics Inc

+ Add to Watchlist

MGNX:US

19.0000 USD 0.5400 2.93%

As of 20:10:00 ET on 10/20/2014.

Snapshot for MacroGenics Inc (MGNX)

Open: 18.3500 Day's Range: 18.3500 - 19.0000 Volume: 69,676
Previous Close: 18.4600 52wk Range: 17.3100 - 41.0000 1-Yr Rtn: -26.07%

Stock Chart for MGNX

No chart data available.
  • MGNX:US 18.9500
  • 1D
  • 1M
  • 1Y
18.4600
Interactive MGNX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MGNX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3200
Est. EPS (USD) (12/2014) -1.3720
Est. PEG Ratio -
Market Cap (M USD) 527.03
Shares Outstanding (M) 27.74
30 Day Average Volume 188,183
Price/Book (mrq) 3.7102
Price/Sale (ttm) 0.8743
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MGNX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MGNX

MacroGenics, Inc. develops novel biologics. The Company specializes in treatments for autoimmune disorders, cancer, and infectious diseases. MacroGenics serves the healthcare industry in the United States.

Scott KoenigPresident/CEO/Co-FounderJames Karrels "Jim"CFO/VP/Secretary
Ezio BonviniSenior VP:ResearchKathryn SteinSenior VP:Product Dev
More Company Profile & Key Executives for MGNX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil